AIM’s pawnbrokers look in great shape, although you wouldn’t believe it from their moribund share prices. Read on here for our thoughts on the latest news from two companies doing nicely from the soaring gold price. Elsewhere, news of a full scale CMA investigation into the veterinary sector has knocked the share price of one of AIM’s largest companies. Could this be a buying opportunity or is there more pain to come? Read on here for our forthright opinion on this and other news. (Premium)
Veterinary pain Shares in veterinary services group CVS Group (AIM:CVSG) tumbled on news that the Competition and Markets Authority (‘CMA’) is initiating a full market investigation into the sector. This followed the preliminary probe announced last September, which also brought a sell-off in CVS shares. The CMA’s full release is here. We covered CVS’s recent results here. The CMA has highlighted multiple concerns in the market, including: - Consumers may not be given enough information to enable them to choose the best veterinary practice or the right treatment for their needs. - Concentrated local markets, in part driven by sector…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login